What works, and what remains to be done, in HIV prevention in the United States

David R Holtgrave, James W. Curran

Research output: Contribution to journalArticle

Abstract

Since the beginning of the HIV epidemic in the United States, HIV prevention programs have prevented hundreds of thousands of HIV infections, and the investment in these programs has actually been cost-saving to society in terms of medical costs averted. A substantial body of evidence exists (including randomized controlled trials and careful meta-analyses) which demonstrates that various HIV prevention services are effective; an increasingly large body of data also demonstrates the cost-effectiveness of these interventions. However, the efforts to utilize these interventions in a comprehensive HIV prevention program are hampered by insufficient funding, imperfect targeting strategies, and a problematic policy environment that creates barriers to the use of some of these life-saving interventions. Progress toward reducing new HIV infections will likely be as much a function of improvements in funding and policies as it will in the development of new tools for HIV prevention.

Original languageEnglish (US)
Pages (from-to)261-275
Number of pages15
JournalAnnual Review of Public Health
Volume27
DOIs
StatePublished - 2006

Fingerprint

HIV
HIV Infections
Costs and Cost Analysis
Cost-Benefit Analysis
Meta-Analysis
Randomized Controlled Trials

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

What works, and what remains to be done, in HIV prevention in the United States. / Holtgrave, David R; Curran, James W.

In: Annual Review of Public Health, Vol. 27, 2006, p. 261-275.

Research output: Contribution to journalArticle

@article{e209e63d0df7457baba8249590039800,
title = "What works, and what remains to be done, in HIV prevention in the United States",
abstract = "Since the beginning of the HIV epidemic in the United States, HIV prevention programs have prevented hundreds of thousands of HIV infections, and the investment in these programs has actually been cost-saving to society in terms of medical costs averted. A substantial body of evidence exists (including randomized controlled trials and careful meta-analyses) which demonstrates that various HIV prevention services are effective; an increasingly large body of data also demonstrates the cost-effectiveness of these interventions. However, the efforts to utilize these interventions in a comprehensive HIV prevention program are hampered by insufficient funding, imperfect targeting strategies, and a problematic policy environment that creates barriers to the use of some of these life-saving interventions. Progress toward reducing new HIV infections will likely be as much a function of improvements in funding and policies as it will in the development of new tools for HIV prevention.",
author = "Holtgrave, {David R} and Curran, {James W.}",
year = "2006",
doi = "10.1146/annurev.publhealth.26.021304.144454",
language = "English (US)",
volume = "27",
pages = "261--275",
journal = "Annual Review of Public Health",
issn = "0163-7525",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - What works, and what remains to be done, in HIV prevention in the United States

AU - Holtgrave, David R

AU - Curran, James W.

PY - 2006

Y1 - 2006

N2 - Since the beginning of the HIV epidemic in the United States, HIV prevention programs have prevented hundreds of thousands of HIV infections, and the investment in these programs has actually been cost-saving to society in terms of medical costs averted. A substantial body of evidence exists (including randomized controlled trials and careful meta-analyses) which demonstrates that various HIV prevention services are effective; an increasingly large body of data also demonstrates the cost-effectiveness of these interventions. However, the efforts to utilize these interventions in a comprehensive HIV prevention program are hampered by insufficient funding, imperfect targeting strategies, and a problematic policy environment that creates barriers to the use of some of these life-saving interventions. Progress toward reducing new HIV infections will likely be as much a function of improvements in funding and policies as it will in the development of new tools for HIV prevention.

AB - Since the beginning of the HIV epidemic in the United States, HIV prevention programs have prevented hundreds of thousands of HIV infections, and the investment in these programs has actually been cost-saving to society in terms of medical costs averted. A substantial body of evidence exists (including randomized controlled trials and careful meta-analyses) which demonstrates that various HIV prevention services are effective; an increasingly large body of data also demonstrates the cost-effectiveness of these interventions. However, the efforts to utilize these interventions in a comprehensive HIV prevention program are hampered by insufficient funding, imperfect targeting strategies, and a problematic policy environment that creates barriers to the use of some of these life-saving interventions. Progress toward reducing new HIV infections will likely be as much a function of improvements in funding and policies as it will in the development of new tools for HIV prevention.

UR - http://www.scopus.com/inward/record.url?scp=33645812933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645812933&partnerID=8YFLogxK

U2 - 10.1146/annurev.publhealth.26.021304.144454

DO - 10.1146/annurev.publhealth.26.021304.144454

M3 - Article

C2 - 16533117

AN - SCOPUS:33645812933

VL - 27

SP - 261

EP - 275

JO - Annual Review of Public Health

JF - Annual Review of Public Health

SN - 0163-7525

ER -